For the attention of those contractors who have are offering the Pharmacy First Sore Throat Service Winter 24/25
Dear Contractor
  • The Pharmacy First Sore Throat Service launched on 1 December 2024 for two months initially.
  • Live training was provided at an ECHO session which has been recorded and is available to view on the ECHO Moodle site for those who were unable to attend the live session.
  • All resources in relation to the service including promotional material is available on the BSO website. Service posters should have been provided by SPPG and should be displayed in the pharmacy.
  • Social cards to be used on social media platforms include:
  • CPNI have developed a training PowerPoint presentation that can be accessed on the CPNI website under Pharmacy First for Sore Throat to further aid contractors and pharmacists in offering the service.

If you require any further information on the Pharmacy First Sore Throat Service Winter 24/25 please contact CPNI offices.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor,
Correspondence has been issued today by SPPG regarding community pharmacy rota remuneration.

SUMMARY

  • A review of community pharmacy rota remuneration has been carried out by SPPG in conjunction with CPNI and recurrent rates have been set effective from 1st December 2024.
    • Weekday rota hourly rate: £108
    • Sunday rota hourly rate: £250
    • Public holiday rota hourly rate: £500
  • SPPG request that rota claims are submitted in a timely manner and should be included with your second monthly submission to BSO.
  • Going forward, pharmacies that provide a public holiday rota should submit a claim form to BSO for payment.
  • Claim forms can be found on the BSO website here.

ACTION

Contractors are asked to:

  • Review the SPPG correspondence issued today regarding community pharmacy rota remuneration.
  • Contact local SPPG offices for further information regarding this correspondence.

CPNI colleagues are also available to assist with any queries.

Yours sincerely,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
The Department of Health NI has issued guidance dated 18 December 2024 detailing upcoming changes under Windsor Framework arrangements from 1 January 2025.

Background

The Windsor Framework sets out the long-term arrangements for the supply of medicines into Northern Ireland. It will ensure that human medicines can be approved and licensed on a UK-wide basis by the UK competent authority, the Medicines and Healthcare products Regulatory Agency, and provides for the disapplication of EU Falsified Medicines Directive (FMD) safety features for medicines marketed and supplied in NI.

The guidance covers topics including:

  • Changes to Medicine Authorisations
  • EU FMD which will no longer apply in NI from 1 January 2025
  • Labelling and Packaging

The guidance also contains links to other supporting documents, and pharmacy contractors may find the section on FAQs particularly helpful.

Action

Contractors are asked to:

  • Note the recent correspondence detailing the upcoming changes under Windsor Framework arrangements (including FMD) from 1 January 2025;
  • Note the additional guidance which is linked to the letter and, in particular, the FAQs which can be found here; and
  • Ensure that all relevant dispensary staff are made aware of the arrangements.

If you have any queries, please direct them in the first instance to mrg_inspectors@health-ni.gov.uk.

CPNI colleagues are also here to help you.

Kind regards

Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs

Dear Colleague
The second update of concessionary prices were granted today for December 2024:
DrugPack SizeConcessionary Price
Ascorbic acid 200mg tablets28£56.45
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel60£27.96
Chloramphenicol 0.5% eye drops10£4.99
Chloramphenicol 1% eye ointment4£3.85
Clarithromycin 250mg/5ml oral suspension70£8.47
Domperidone 10mg tablets100£2.63
Domperidone 10mg tablets30£0.79
Fenofibrate micronised 200mg capsules28£3.61
Isosorbide mononitrate 20mg tablets56£4.00
Isosorbide mononitrate 40mg tablets56£2.44
Lactulose 3.1-3.7g/5ml oral solution500£4.63
Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops2.5£4.27
Metformin 500mg modified-release tablets56£2.50
Morphine sulfate 10mg/1ml solution for injection ampoules10£5.97
Nortriptyline 10mg tablets100£3.90
Olanzapine 20mg tablets28£3.25
Ondansetron 8mg tablets10£4.78
Perindopril erbumine 8mg tablets30£2.19
Quetiapine 100mg tablets60£10.17
Quetiapine 150mg tablets60£9.54
Quetiapine 200mg tablets60£13.45
Quetiapine 25mg tablets60£2.85
Telmisartan 20mg tablets28£2.24
Venlafaxine 225mg modified-release capsules28£20.71

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor

Background

The Department of Health’s Controlled Drug Accountable Officer (CDAO) has issued correspondence dated 16 December 2024 in respect of a planned change to the process for notifying the CDAO of controlled drugs concerns and incidents.  The documents can be accessed here and here.

On 6 January 2025, it is planned that the CDAO notification process will move to an online reporting mechanism specifically for Northern Ireland which is available at www.cdreporting.co.uk.

Action

Contractors are asked to:

  • Note the recent correspondence detailing the new online reporting system;
  • Note that the new reporting system was covered in an ECHO session on the 19 November 2024 and is available to watch again at Dashboard | Project ECHO, and that a guide is also appended to the CDAO letter; and
  • Ensure that all relevant dispensary staff are made aware of the new system.

If you have any queries, please direct them in the first instance to SPPGCDOccurrence@hscni.net.  CPNI colleagues are also here to help you.

Kind regards

Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs

For the attention of Community Pharmacies providing the Autumn 2024 COVID-19 and Seasonal Influenza Community Pharmacy Vaccination Service
Dear Colleague
SPPG have issued correspondence providing an update in relation to the Autumn 2024 COVID-19 and Seasonal Influenza vaccination programme.

SUMMARY

  • The target date of 6 December 2024 for completion of care home vaccinations has now passed. Any outstanding vaccination records should be added to VMS as soon as possible to ensure clinical governance and to provide assurance to the PHA and DoH that residents are vaccinated.
  • The CPVS service specification states: ‘A vaccination record should be made on VMS on the same date as the vaccination’. Payment is based on the record being added to the system.
  • High-risk poultry and avian animal health workers are eligible for the flu vaccination this Autumn 2024 and have been added to the list of eligible cohorts. Further information can be found in the CMO letter here.
  • VMS has been updated to include the option of ‘bird culler’ when selecting patient risk category.
  • The vaccination download report on VMS has been updated to only include records from the past 18 months. All patient records and vaccination history will still be visible on VMS and will not be affected by this change.
  • The correspondence includes the schedule for Movianto over the Christmas holidays. The last delivery dates before Christmas and New Year will be 24th December 2024 and 31st December 2024. Orders should be placed in a timely manner.
  • Due to annual stock taking at Movianto, orders for Flu vaccines only, that are needed for 31st December 2024 will need to be placed by 10am on Monday 30th December 2024. NB: Any orders that include Covid vaccines will need to be placed on Tuesday 24th December to be delivered by 31st December 2024.

ACTION

Contractors providing the service should:

Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive